Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-B1, and vascular endothelial growth factor.

Translated title of the contribution: Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-B1, and vascular endothelial growth factor.
  • A.C. Abrahams
  • , S.M. Habib
  • , A. Dendooven
  • , J.W. van der Veer
  • , R.J. Toorop
  • , M.G.H. Betjes
  • , C.J.E. Watson
  • , B Riser
  • , M.C. Verhaar
  • , T.Q. Nguyen
  • , W.H. Boer

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPatients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-B1, and vascular endothelial growth factor.
Original languageUndefined/Unknown
Pages (from-to)e112050
Number of pages1
JournalPLoS ONE [E]
Volume9
Issue number11
Publication statusPublished - 2014

Cite this